Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 16, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
On October 13, 2006, Abacus (GSK) Trustees Limited, acting as trustee for the GlaxoSmithKline Employee Trust ("the GSK Trust"), transferred 10,170 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991. The Company was advised of these transactions on October 16, 2006.
Outlook, Risks, and Management Commentary
The GSK Trust is a discretionary trust where all current and former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. Three directors—Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop—are noted as having an interest in the shares held in the GSK Trust in the same capacity as other employees. The filing contains no guidance, outlook, or discussion of risks beyond the disclosure of this specific transaction.
Investor Verification Points
- Verify the total number of shares transferred (10,170) and the date of transfer (October 13, 2006).
- Confirm the identity of the trustee (Abacus (GSK) Trustees Limited) and the specific plan involved (SmithKline Beecham Employee Share Option Plan 1991).
- Note that three directors have an indirect interest in the trust shares as potential beneficiaries.
- Understand that this filing does not report on the company's financial performance for the period.